期刊
KIDNEY INTERNATIONAL
卷 76, 期 4, 页码 376-382出版社
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2009.231
关键词
anemia; mTOR; posttransplant; renal; sirolimus
资金
- MediMedia Educational Group
Posttransplant anemia is a common problem that may hinder patients' quality of life. It occurs in 12 to 76% of patients, and is most common in the immediate posttransplant period. A variety of factors have been identified that increase the risk of posttransplant anemia, of which the level of renal function is most important. Sirolimus, a mammalian target of rapamycin inhibitor, has been implicated as playing a special role in posttransplant anemia. This review considers anemia associated with sirolimus, including its presentation, mechanisms, and management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据